Cargando…

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

Detalles Bibliográficos
Autores principales:	Sablerolles, Roos S. G., Goorhuis, Abraham, GeurtsvanKessel, Corine H., de Vries, Rory D., Huckriede, Anke L. W., Koopmans, Marion P. G., Lafeber, Melvin, Postma, Douwe F., van Baarle, Debbie, Visser, Leo G., Dalm, Virgil A. S. H., Kootstra, Neeltje A., Rietdijk, Wim J. R., van der Kuy, P. Hugo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529966/ https://www.ncbi.nlm.nih.gov/pubmed/34691071 http://dx.doi.org/10.3389/fimmu.2021.753319

Ejemplares similares

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022)

Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
por: Tan, Ngoc H., et al.
Publicado: (2022)

Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers
por: Sablerolles, Roos S G, et al.
Publicado: (2022)

Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
por: Geers, Daryl, et al.
Publicado: (2022)

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial
por: Tan, Ngoc H, et al.
Publicado: (2023)

Evaluating novel COVID-19 vaccines in the current chapter of the pandemic
por: GeurtsvanKessel, Corine H, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

Understanding the association between sleep, shift work and COVID‐19 vaccine immune response efficacy: Protocol of the S‐CORE study
por: Lammers‐van der Holst, Heidi M., et al.
Publicado: (2021)

Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands
por: Phan, My V. T., et al.
Publicado: (2019)

Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
por: van Leeuwen, Leanne P. M., et al.
Publicado: (2023)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2021)

Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7
por: Embregts, Carmen W. E., et al.
Publicado: (2021)

No association between use of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID‐19 in the COvid MEdicaTion (COMET) study
por: Sablerolles, Roos S. G., et al.
Publicado: (2021)

Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
por: Voermans, Jolanda J.C., et al.
Publicado: (2019)

SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence
por: den Hartog, Gerco, et al.
Publicado: (2020)

Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection
por: Neyt, Katrijn, et al.
Publicado: (2016)

Tertiary lymphoid organs in infection and autoimmunity
por: Neyt, Katrijn, et al.
Publicado: (2012)

COvid MEdicaTion (COMET) study: protocol for a cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2020)

Shedding of Yellow Fever Virus From an Imported Case in the Netherlands After Travel to Brazil
por: Phan, My V T, et al.
Publicado: (2020)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020
por: van Beek, Janko, et al.
Publicado: (2022)

Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2022)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages
por: Embregts, Carmen W.E., et al.
Publicado: (2023)

Th(1)-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
por: den Hartog, Yvette, et al.
Publicado: (2023)

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories
por: van den Beld, Maaike J. C., et al.
Publicado: (2021)

Genomic sequence of yellow fever virus from a Dutch traveller returning from the Gambia-Senegal region, the Netherlands, November 2018
por: Phan, My VT, et al.
Publicado: (2019)

High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients
por: Hoek, Rogier AS, et al.
Publicado: (2022)

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person
por: Munnink, Bas B. Oude, et al.
Publicado: (2022)

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Sanders, Jan-Stephan F, et al.
Publicado: (2022)

Ongoing rabies outbreak in dogs of unprecedented scale and human cases in Nelson Mandela Bay Municipality, South Africa, up to 13 February 2022
por: Ravensberg, Matthijs F, et al.
Publicado: (2022)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
por: Malahe, S. Reshwan K., et al.
Publicado: (2023)

2939. Hepatitis A vaccine immunogenicity in an immunocompromised population: a prospective cohort study
por: Schnyder, Jenny, et al.
Publicado: (2023)

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
por: Oosting, Sjoukje F, et al.
Publicado: (2021)

Two clinical cases of renal syndrome caused by Dobrava/Saaremaa hantaviruses imported to the Netherlands from Poland and Belarus, 2012–2014
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2016)

Dried blood spot cards: A reliable sampling method to detect human antibodies against rabies virus
por: Doornekamp, Laura, et al.
Publicado: (2020)

Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients
por: van Riel, Debby, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_otg3ne8liuf5lqjgcvdu5t6pvr